| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000040523 |
| Receipt No. | R000046259 |
| Scientific Title | Evaluation test on the influence of intake banana on changes of Intestinal flora and Vitamin B6. |
| Date of disclosure of the study information | 2020/05/26 |
| Last modified on | 2020/11/26 (Ver. 2) |
| Basic information | ||
| Public title | Evaluation test on the influence of intake banana on changes of Intestinal flora and Vitamin B6. | |
| Acronym | Evaluation test on the influence of intake banana on changes of Intestinal flora and Vitamin B6. | |
| Scientific Title | Evaluation test on the influence of intake banana on changes of Intestinal flora and Vitamin B6. | |
| Scientific Title:Acronym | Evaluation test on the influence of intake banana on changes of Intestinal flora and Vitamin B6. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluate the changes of Intestinal flora and Vitamin B6 by banana intake for 4 weeks. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | -Intestinal flora
-Vitamin B6 At the beginning of the test or after the intake for 4weeks. |
| Key secondary outcomes | -AGEs
-Blood test (total protein, albumin, total cholesterol, HDL-cholesterol, LDL-cholesterol, blood neutral fat (TG), urea nitrogen , creatinine, uric acid, AST, ALT, ALP,HbA1c, sodium, potassium, chlorine, calcium, magnesium, phosphorus, serum iron, complete blood count) -Physical examination (body weight, BMI) -Blood pressure (systolic blood pressure, diastolic blood pressure),Pulse At the beginning of the test or after the intake for 4weeks. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -investigator(s) and assessor(s) are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of 2 bananas daily for 4 weeks. | |
| Interventions/Control_2 | none | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Persons who received a sufficient explanation of the purpose and contents of the study, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2.Male and female who are 30 years old or more and under 64 years old |
|||
| Key exclusion criteria | 1.Persons who have any disease and are judged to have necessary treatment by the principal investigator.
2.Persons who have severe anemia. 3.Persons who are pregnant, planning or hoping to be pregnant during the study period, currently lactating. 4.Persons who may cause allergic symptoms to test foods. 5.Persons who have an addiction to alcohol or a mental disease. 6.Persons who are smokers or have been smoking within last 10 years. 7.Persons whose life style will change during the study period. 8.Persons who plan to intake new health functional foods and supplement foods during the study period. 9.Persons who were hospitalized and received treatment in the past 6 months. 10.Persons who participate in other clinical studies or participated in the last 3 months or plan to participate in other clinical studies. 11. Persons who were judged as inappropriate for subjects by the principal investigator. |
|||
| Target sample size | 34 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Akasaka Family Clinic | ||||||
| Division name | Clinic Director | ||||||
| Zip code | 107-0052 | ||||||
| Address | Akasaka Plaza bldg. 3F, 2-15-15 Akasaka, Minato-ku, Tokyo, JAPAN | ||||||
| TEL | 03-5562-8825 | ||||||
| info@afc.tokyo | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Healthcare Systems Co., Ltd. | ||||||
| Division name | Research and Development Department | ||||||
| Zip code | 105-0004 | ||||||
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN | ||||||
| TEL | 03-6809-2722 | ||||||
| Homepage URL | |||||||
| masudat@hc-sys.jp | |||||||
| Sponsor | |
| Institute | Akasaka Family Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Banana Importers Association. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Ethics Committee of Healthcare Systems Co., Ltd. |
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
| Tel | 03-6809-2722 |
| soumu@hc-sys.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046259 |